New study maps best antibiotic steps for fever in cancer patients
NCT ID NCT07204522
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a specific order of antibiotics for cancer patients who develop fever due to low white blood cells (febrile neutropenia). Twenty adults with blood cancers will receive a carbapenem first, then add vancomycin or linezolid if fever persists, and finally an antifungal if needed. The goal is to see how well this step-up plan controls fever and infection, and to monitor for side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Carbapenems, vancomycin, linezolid, antifungal agents, ceftazidime-avibactam, aztreonam
- What this could lead to
- If successful, this could establish a clear, effective treatment roadmap for managing fever in cancer patients with weakened immune systems, potentially reducing complications.
- What could go wrong
- This is a small, early observational study with only 20 participants, so results may not apply to all patients. The step-up approach may not work for everyone and carries risks like side effects from multiple antibiotics.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Shanxi Bethune Hospital
RECRUITINGTaiyuan, Shanxi, 030000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could muscle loss predict blood cancer outcomes?
- Can a Triple-Action antibody deepen remissions in myeloma?
- Can a Low-Dose antifungal shield vulnerable patients from deadly fungal infections?
- Can a simple blood test outsmart deadly fungal infections in blood cancer?
- Can a gentler chemo prep make stem cell transplants safer for blood cancer patients?
- Can engineered immune cells tackle brain lymphoma?